cellectis
AstraZeneca and Cellectis to collaborate for cell therapy and genomic medicine development
November 1, 2023Research and Development AstraZeneca, CGT, Pharmacy, cell therapy, cellectis, genomic medicine
AstraZeneca has announced a collaboration and investment agreement with Cellectis for the development of next generation cell and gene therapeutics …
Cellectis given another shot at off-the-shelf CAR-T
November 8, 2017Medical Communications, Research and Development CAR-T, biotech, cellectis, drugs, pharma, pharmaceutical
It is easy to forget the very real dangers that CAR-T treatment present to patients after Novartis and Gilead both …
FDA halts trial after first CAR T-associated patient death
September 6, 2017Research and Development CAR T, CAR-T, Cancer, FDA, cellectis, leukaemia, patient death, pharma, pharmaceutical
French clinical-stage biopharma firm Cellectis has received an order from the FDA to halt its study of CAR T therapy …
Servier signs leukaemia deal
February 19, 2014Research and Development, Sales and Marketing Servier, UCART19, car, cellectis, leaukaemia
French firms Servier and small biopharma cancer specialist Cellectis have signed a deal to develop and commercialise one drug targeting …
Contract research news in brief
October 15, 2010Research and Development Clinipace, Covance, PPD, Quintiles, Synexus, cellectis
Our latest crop of contract research news includes updates from Clinipace, PPD, Cellectis bioresearch, Covance, Quintiles and Synexus. US contract …
Cellectis appoints Dr Sylvie Delassus Senior Vice President Communications
October 20, 2009Research and Development appointment, cellectis, research and development
French genome engineering company Cellectis has appointed Dr Sylvie Delassus senior vice president communications and a member of its executive …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
